Le Guellec C - Search Results

1

New sampling strategy using a Bayesian approach to assess iohexol clearance in kidney transplant recipients.

Benz-de Bretagne I, Le Guellec C, Halimi JM, Gatault P, Barbet C, Alnajjar A, Büchler M, Lebranchu Y, Andres CR, Vourcʼh P, Blasco H. Benz-de Bretagne I, et al. Among authors: le guellec c. Ther Drug Monit. 2012 Jun;34(3):289-97. doi: 10.1097/FTD.0b013e31824a6534. Ther Drug Monit. 2012. PMID: 22585184 Clinical Trial.

2

Population pharmacokinetics and Bayesian estimation of mycophenolic acid concentrations in stable renal transplant patients.

Le Guellec C, Bourgoin H, Büchler M, Le Meur Y, Lebranchu Y, Marquet P, Paintaud G. Le Guellec C, et al. Among authors: le meur y. Clin Pharmacokinet. 2004;43(4):253-66. doi: 10.2165/00003088-200443040-00004. Clin Pharmacokinet. 2004. PMID: 15005639 Clinical Trial.

3

Bayesian estimation of cyclosporin exposure for routine therapeutic drug monitoring in kidney transplant patients.

Bourgoin H, Paintaud G, Büchler M, Lebranchu Y, Autret-Leca E, Mentré F, Le Guellec C. Bourgoin H, et al. Among authors: le guellec c. Br J Clin Pharmacol. 2005 Jan;59(1):18-27. doi: 10.1111/j.1365-2125.2005.02200.x. Br J Clin Pharmacol. 2005. PMID: 15606436 Free PMC article.

4

Simultaneous estimation of cyclosporin and mycophenolic acid areas under the curve in stable renal transplant patients using a limited sampling strategy.

Le Guellec C, Büchler M, Giraudeau B, Le Meur Y, Gakoué JE, Lebranchu Y, Marquet P, Paintaud G. Le Guellec C, et al. Among authors: le meur y. Eur J Clin Pharmacol. 2002 Jan;57(11):805-11. doi: 10.1007/s00228-001-0389-2. Eur J Clin Pharmacol. 2002. PMID: 11868803 Clinical Trial.

5

Urinary elimination of coproporphyrins is dependent on ABCC2 polymorphisms and represents a potential biomarker of MRP2 activity in humans.

Benz-de Bretagne I, Respaud R, Vourc'h P, Halimi JM, Caille A, Hulot JS, Andres CR, Le Guellec C. Benz-de Bretagne I, et al. Among authors: le guellec c. J Biomed Biotechnol. 2011;2011:498757. doi: 10.1155/2011/498757. Epub 2011 Mar 14. J Biomed Biotechnol. 2011. PMID: 21541183 Free PMC article.

6

Assessing the metabolic effects of calcineurin inhibitors in renal transplant recipients by urine metabolic profiling.

Diémé B, Halimi JM, Emond P, Büchler M, Nadal-Desbarat L, Blasco H, Le Guellec C. Diémé B, et al. Among authors: le guellec c. Transplantation. 2014 Jul 27;98(2):195-201. doi: 10.1097/TP.0000000000000039. Transplantation. 2014. PMID: 24598938

7

Correction: Elucidating time-dependent changes in the urinary metabolome of renal transplant patients by a combined ¹H NMR and GC-MS approach.

Muhrez K, Nadal-Desbarats L, Halimi JM, Dieme B, Büchler M, Emond P, Blasco H, Le Guellec C. Muhrez K, et al. Among authors: le guellec c. Mol Biosyst. 2017 Jan 31;13(2):432. doi: 10.1039/c7mb90005h. Mol Biosyst. 2017. PMID: 28102871

8

Relationship between calcineurin inhibition and plasma endothelin concentrations in cyclosporine-A-treated kidney transplant patients.

Büchler M, Leibenguth P, Le Guellec C, Carayon A, Watier H, Odoul F, Autret-Leca E, Lebranchu Y, Paintaud G. Büchler M, et al. Among authors: le guellec c. Eur J Clin Pharmacol. 2004 Dec;60(10):703-8. doi: 10.1007/s00228-004-0860-y. Epub 2004 Nov 20. Eur J Clin Pharmacol. 2004. PMID: 15619133 Clinical Trial.

9

Quantification of coproporphyrin isomers I and III in urine by HPLC and determination of their ratio for investigations of multidrug resistance protein 2 (MRP2) function in humans.

Respaud R, Benz-de Bretagne I, Blasco H, Hulot JS, Lechat P, Le Guellec C. Respaud R, et al. Among authors: le guellec c. J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Nov 15;877(30):3893-8. doi: 10.1016/j.jchromb.2009.09.047. Epub 2009 Oct 8. J Chromatogr B Analyt Technol Biomed Life Sci. 2009. PMID: 19836315

10

A case of severe toxicity during coadministration of vincristine and piperacillin: are drug transporters involved in vincristine hypersensitivity and drug-drug interactions?

Le Guellec C, Benz-de Bretagne I, Jonville-Bera AP, Tarfaoui N, Andres CR, Gendrot C, Jourdain A. Le Guellec C, et al. J Pediatr Hematol Oncol. 2012 Nov;34(8):e341-3. doi: 10.1097/MPH.0b013e318257a4ae. J Pediatr Hematol Oncol. 2012. PMID: 22627576

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters